Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Nastoupil LJ, Chin CK, Westin JR, Fowler NH, Samaniego F, Cheng X, Ma MCJ, Wang Z, Chu F, Dsouza L, Obi C, Mims J, Feng L, Zhou S, Green M, Davis RE, Neelapu SS. Nastoupil LJ, et al. Among authors: obi c. Blood Adv. 2022 Feb 22;6(4):1143-1151. doi: 10.1182/bloodadvances.2021006240. Blood Adv. 2022. PMID: 35015819 Free PMC article. Clinical Trial.
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial.
Gurumurthi A, Chin CK, Feng L, Fowler NH, Strati P, Hagemeister FB, Fayad LE, Westin JR, Obi C, Arafat J, Nair R, Steiner RE, Neelapu SS, Flowers CR, Nastoupil LJ. Gurumurthi A, et al. Among authors: obi c. EClinicalMedicine. 2024 Jul 27;74:102747. doi: 10.1016/j.eclinm.2024.102747. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39161543 Free PMC article.
Nanotoxicology: developments and new insights.
Abonyi HN, Peter IE, Onwuka AM, Achile PA, Obi CB, Akunne MO, Ejikeme PM, Amos S, Akunne TC, Attama AA, Akah PA. Abonyi HN, et al. Among authors: obi cb. Nanomedicine (Lond). 2024 Dec 26:1-17. doi: 10.1080/17435889.2024.2443385. Online ahead of print. Nanomedicine (Lond). 2024. PMID: 39723590 Review.
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry.
Silverberg JI, Calimlim BM, Grada A, Bunick CG, Gooderham MJ, Shi VY, Obi C, Knapp KD, Munoz B, Crawford JM, Paller AS. Silverberg JI, et al. Among authors: obi c. J Dermatolog Treat. 2024 Dec;35(1):2428729. doi: 10.1080/09546634.2024.2428729. Epub 2024 Dec 11. J Dermatolog Treat. 2024. PMID: 39662888 Free article.
Strengthening Capacity for Tailored Immunization Programs Using Adult Learning Principles: A Case Study from Nigeria.
Obi-Jeff C, Oguntimehin F, Adejumo A, Ibrahim A, Ade-Banjo O, Gadzama D, Okoli N, Obi C, Olorupo R, Martins I, Usman A, Joy A, Chadwafwa T, Onimisi A. Obi-Jeff C, et al. Among authors: obi c. Glob Health Sci Pract. 2024 Oct 29;12(5):e2300465. doi: 10.9745/GHSP-D-23-00465. Print 2024 Oct 29. Glob Health Sci Pract. 2024. PMID: 39293821 Free PMC article.
Venous Compressive Disorders.
Young VA, Obi C, Oladini LK, Josephs SC, Hofmann LV. Young VA, et al. Among authors: obi c. Tech Vasc Interv Radiol. 2024 Jun;27(2):100964. doi: 10.1016/j.tvir.2024.100964. Epub 2024 Jun 14. Tech Vasc Interv Radiol. 2024. PMID: 39168547 Review.
174 results